MENU
+Compare
WVE
Stock ticker: NASDAQ
AS OF
Dec 18, 04:29 PM (EDT)
Price
$13.34
Change
-$1.11 (-7.68%)
Capitalization
2.2B

WVE Wave Life Sciences Ltd Forecast, Technical & Fundamental Analysis

a provider of nucleic acid therapeutics

Industry Biotechnology
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for WVE with price predictions
Dec 17, 2024

WVE's Stochastic Oscillator is remaining in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 17, 2024. You may want to consider a long position or call options on WVE as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

WVE moved above its 50-day moving average on December 17, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WVE advanced for three days, in of 272 cases, the price rose further within the following month. The odds of a continued upward trend are .

WVE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 148 cases where WVE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for WVE moved out of overbought territory on November 12, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WVE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. WVE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.552) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). WVE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (33.898) is also within normal values, averaging (260.687).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

WVE is expected to report earnings to fall 59.57% to -18 cents per share on February 27

Wave Life Sciences Ltd WVE Stock Earnings Reports
Q4'24
Est.
$-0.19
Q3'24
Missed
by $0.19
Q2'24
Missed
by $0.04
Q1'24
Missed
by $0.03
Q4'23
Beat
by $0.08
The last earnings report on November 12 showed earnings per share of -46 cents, missing the estimate of -28 cents. With 279.15K shares outstanding, the current market capitalization sits at 2.20B.
A.I. Advisor
published General Information

General Information

a provider of nucleic acid therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Marina One East Tower
Phone
+65 62363388
Employees
268
Web
https://www.wavelifesciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGIPX20.78N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps P
BGEFX14.09-0.02
-0.15%
Baillie Gifford International Growth 4
GLDCX19.38-0.11
-0.56%
Gabelli Gold C
RYZCX28.60-0.22
-0.76%
Rydex Precious Metals C
LMASX36.40-0.44
-1.19%
ClearBridge Small Cap C

WVE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been loosely correlated with PRQR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
+7.43%
PRQR - WVE
47%
Loosely correlated
+19.03%
KRRO - WVE
40%
Loosely correlated
+3.32%
ATNF - WVE
39%
Loosely correlated
N/A
RIGL - WVE
35%
Loosely correlated
-3.61%
ABOS - WVE
35%
Loosely correlated
-0.51%
More